SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-044626
Filing Date
2021-08-16
Accepted
2021-08-16 16:08:23
Documents
72
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q elox-10q_20210630.htm   iXBRL 10-Q 2351376
2 EX-31.1 elox-ex311_6.htm EX-31.1 8707
3 EX-31.2 elox-ex312_12.htm EX-31.2 9235
4 EX-32.1 elox-ex321_10.htm EX-32.1 7031
5 EX-32.2 elox-ex322_11.htm EX-32.2 6861
  Complete submission text file 0001564590-21-044626.txt   6985686

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA elox-20210630.xsd EX-101.SCH 45679
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE elox-20210630_cal.xml EX-101.CAL 58650
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elox-20210630_def.xml EX-101.DEF 98883
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE elox-20210630_lab.xml EX-101.LAB 342903
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elox-20210630_pre.xml EX-101.PRE 260951
11 EXTRACTED XBRL INSTANCE DOCUMENT elox-10q_20210630_htm.xml XML 1139444
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 211178121
SIC: 8731 Services-Commercial Physical & Biological Research